TRIB

Trinity Biotech
TRIB

Overview Fund Trends Analyst Outlook Journalist POV

41 hedge funds and large institutions have $30.2M invested in Trinity Biotech in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.76M
2
+$439K
3
+$345K
4
HA
Heartland Advisors
Wisconsin
+$211K
5
BlackRock
BlackRock
New York
+$141K

Top Sellers

1
-$4.02M
2
-$1.21M
3
-$1.15M
4
Boston Partners
Boston Partners
Massachusetts
-$292K
5
VF
Virtu Financial
New York
-$135K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$31K
27
$28K
28
$27K
29
$27K
30
$24K
31
$23K
32
$11K
33
$10K
34
$7K
35
$5K
36
$3K
37
$1K
38
$1K
39
–
40
–
41
–
42
–
43
–
44
–
1
2